Related Experiment Video
Updated: Sep 3, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Changes in liver enzymes and association with prognosis in patients with COVID-19: a retrospective case-control study
Farhad Shaveisi-Zadeh1, Bahram Nikkho2, Mohamaad Bagher Khadem Erfan3
1Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Insights
This study investigated COVID-19 patient lab results, finding elevated liver enzymes (ALT) and altered blood cell counts. However, these markers did not correlate with patient mortality, suggesting caution in attributing liver damage solely to SARS-CoV-2.
Area of Science:
- Infectious Diseases
- Hepatology
- Hematology
Background:
- COVID-19 poses a significant global health risk.
- Understanding the laboratory manifestations of COVID-19 is crucial for patient management.
- Liver enzyme alterations are frequently observed in COVID-19 patients.
Purpose of the Study:
- To examine laboratory investigations in COVID-19 patients.
- To specifically analyze liver enzyme levels in relation to COVID-19 infection.
- To investigate the association between laboratory findings and patient survival.
Main Methods:
- Retrospective, single-center study of 77 COVID-19 patients.
- Analysis of complete blood cell count, WBC, NLR, PLR, LMR, ALT, and alkaline phosphatase.
- Comparison of laboratory findings between COVID-19 patients and 63 healthy controls.
Main Results:
- COVID-19 patients exhibited elevated ALT, WBC, neutrophils, NLR, and PLR compared to controls.
- Patients with COVID-19 showed decreased platelet counts and lymphocytes.
- Elevated AST, NLR, PLR, and LMR were observed but not linked to mortality.
Conclusions:
- While certain laboratory markers are altered in COVID-19, they do not predict mortality.
- Elevated AST levels in COVID-19 patients require careful interpretation due to AST presence in other tissues.
- Further research is needed to clarify the direct impact of SARS-CoV-2 on liver function.
Objective:
COVID-19 has recently emerged as a serious threat to global health. This study examined the laboratory investigations of patients with COVID-19, with an emphasis on liver enzymes.
Methods:
This retrospective, single-center study was performed on patients with COVID-19 who were admitted to Imam Reza Hospital, Iran from March 2020 to February 2021. Laboratory tests included a complete blood cell count, white blood cell (WBC) count, neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), lymphocyte/monocyte ratio, and levels of aspartate aminotransferase, alanine aminotransferase (ALT), and alkaline phosphatase. Patient survival was among the outcome measures investigated in association with laboratory findings.
Results:
We enrolled 77 patients with COVID-19 and 63 healthy controls. In comparison with the control group, patients with COVID-19 showed COVID-19 increased ALT, WBC, neutrophils, NLR, and PLR, and decreased platelet counts and lymphocytes.
Conclusion:
Although elevated levels of AST, NLR, PLR, and LMR were found in patients with COVID-19, they were not linked to mortality. Given the presence of AST in other tissues, the influence of SARS-CoV-2 on the liver should be interpreted with caution.
More Related Videos
09:44Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Hepatic Drug Excretion: Influencing Factors
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...